Literature DB >> 15057426

[Possible interventions in impaired wound healing].

S Coerper1, S Beckert, H D Becker.   

Abstract

Chronic wounds are long-term results of various diseases. Evaluation and therapy of the underlying disorder must be the first goal of a comprehensive wound care protocol. Treatment of local (i.e. wound infection, necrosis, or foreign body) or systemic (i.e. diabetes, immunosuppression, or patient compliance) disturbing factors is the second major step for appropriate wound care. The third major point is wound bed preparation (i.e. debridement, moist wound dressings, or VAC therapy), and wound stimulation. After appropriate wound bed preparation, wounds can be closed by plastic surgery or wound stimulation through various agents (i.e. protease inhibitors, growth factors, or tissue engineering).

Entities:  

Mesh:

Year:  2004        PMID: 15057426     DOI: 10.1007/s00104-004-0843-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  30 in total

1.  [Biosurgery - maggots, are they really the better surgeons?].

Authors:  W Fleischmann; M Russ; D Moch; C Marquardt
Journal:  Chirurg       Date:  1999-11       Impact factor: 0.955

2.  Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc.

Authors:  A I Rojas; T J Phillips
Journal:  Dermatol Surg       Date:  1999-08       Impact factor: 3.398

3.  Limb salvage after successful pedal bypass grafting is associated with improved long-term survival.

Authors:  M Kalra; P Gloviczki; T C Bower; J M Panneton; W S Harmsen; G D Jenkins; A W Stanson; B J Toomey; L G Canton
Journal:  J Vasc Surg       Date:  2001-01       Impact factor: 4.268

4.  A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.

Authors:  V Falanga; M Sabolinski
Journal:  Wound Repair Regen       Date:  1999 Jul-Aug       Impact factor: 3.617

5.  Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

Authors:  A Veves; V Falanga; D G Armstrong; M L Sabolinski
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

6.  Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group.

Authors:  D L Steed; D Donohoe; M W Webster; L Lindsley
Journal:  J Am Coll Surg       Date:  1996-07       Impact factor: 6.113

7.  Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance.

Authors:  Georges Ha Van; Hubert Siney; Agnes Hartmann-Heurtier; Sophie Jacqueminet; Françoise Greau; André Grimaldi
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

8.  The vacuum assisted closure device: a method of securing skin grafts and improving graft survival.

Authors:  Lynette A Scherer; Stephen Shiver; Michael Chang; J Wayne Meredith; John T Owings
Journal:  Arch Surg       Date:  2002-08

9.  Human epidermal growth factor enhances healing of diabetic foot ulcers.

Authors:  Man Wo Tsang; Wan Keung R Wong; Chi Sang Hung; Kwok-Man Lai; Wegin Tang; Elaine Y N Cheung; Grace Kam; Leo Leung; Chi Wai Chan; Chung Min Chu; Edward K H Lam
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

10.  Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis.

Authors:  R E Horch; H Bannasch; J Kopp; C Andree; G B Stark
Journal:  Cell Transplant       Date:  1998 May-Jun       Impact factor: 4.139

View more
  1 in total

1.  Growth hormone abolishes the negative effects of everolimus on intestinal wound healing.

Authors:  Markus Alexander Küper; Sebastian Trütschel; Jürgen Weinreich; Alfred Königsrainer; Stefan Beckert
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.